1. Home
  2. KRYS

KRYS

Krystal Biotech Inc.

as 04-18-2025 1:38pm EST

$
-
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Founded: 2015 Country:
United States
United States
Employees: N/A City: PITTSBURGH
Market Cap: N/A IPO Year: 2017
Target Price: $220.00 AVG Volume (30 days): 339.7K
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 3.00 EPS Growth: 669.23
52 Week Low/High: $141.72 - $219.34 Next Earning Date: 05-06-2025
Revenue: $290,515,000 Revenue Growth: 473.02%
Revenue Growth (this year): 60.88% Revenue Growth (next year): 45.27%

KRYS Daily Stock ML Predictions

Stock Insider Trading Activity of Krystal Biotech Inc. (KRYS)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Krishnan Krish S KRYS President and CEO Mar 13 '25 Sell $177.74 50,000 $8,889,524.59 1,556,956
Krishnan Suma KRYS President, R&D Mar 13 '25 Sell $177.74 50,000 $8,889,524.59 1,533,056
Romano Kathryn KRYS Chief Accounting Officer Feb 26 '25 Sell $175.22 750 $131,415.00 12,604

Share on Social Networks: